This is how the feasibility study pictures part of the new innovation district. The old buildings occupying this part of Oslo (Forskningsparken/ Blindern and Gaustad) today will be left standing, with new elements added. Illustration: Oslo Science City

New feasibility study

Illustrasjon av Oslo SCIENCE Ciity, hvordan det kan se ut.Oslo Science City

The innovation district Oslo Science City released a new feasibility study. The ambition is to develop a world-leading innovation district in the Norwegian capital.

Oslo Science City is the first innovation district in Norway. The members are the University of Oslo, Oslo University Hospital, South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF), Sintef, NGI, Ferd, Studentsamskipnaden i Oslo, Oslo Pensjonsforsikring, the City of Oslo, and Oslo Cancer Cluster.

The district mobilises 7 500 researchers, 30 000 students, and 300 start-ups in developing ecosystems for innovation and green transformation, bringing together educational institutions, researchers, the business community, and the public sector.

Launched at City Hall

On Tuesday 30 November, the innovation district published its new feasibility study during a reception in the Oslo City Hall, with H.R.H. the Crown Prince of Norway, the Minister of Climate and Environment, the City Council Leader, and 600 guests present.

“The study presents the possibilities we have in front of us. We must grasp them! If we do so in a good way, it will strengthen Oslo’s international position as a knowledge capital. There is a big potential in developing new knowledge, new solutions, and sustainable jobs,” said City Council Leader Raymond Johansen in a press release by Oslo Science City.

Oslo Cancer Cluster is a member of Oslo Science City, with the area surrounding our Innovation Park and the Radium Hospital as one of six geographical focus areas in the innovation district.

Group picture of the prominent guests and partners behind the study at Oslo City Hall. Photo: Oslo Science City


About the feasibility study

Oslo Science City’s members are to develop the area from Majorstuen via Marienlyst and Blindern to Gaustad and Ullevål stadion, and also the Radium Hospital, to become a world leading innovation district contributing to a sustainable and modern Norway.

The study is made by A-LAB, Bjarke Ingels Group (BIG), Civitas, Comte Bureau and Menon Economics. For the time being, it is available in Norwegian only.

You can download the feasibility study from the Oslo Science City webpage.

Illustration of part of Blindern area in the future.

This is how the feasibility study pictures part of the new innovation district (Blindern/Majorstuen) in the future. Illustration: Oslo Science City